ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced the commercial release of its innovative new biologic grafting system for use in core decompression surgical procedures. The core decompression surgical procedure is commonly used in treating patients with early stage avascular necrosis (AVN) of the hip. The biologic grafting system combines Wright’s new X-REAM™ Expandable Reamer with a simplified procedure kit that includes Wright’s proprietary PRO-DENSE™ Injectable Graft.
